Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Repligen Earnings Preview
Motley Fool
Monday, June 6, 2011 - 9:32pm
tags:
earnings, Repligen
ASCO '11: Exelixis Updates Prostate Cancer Data
TheStreet.com
Monday, June 6, 2011 - 9:28pm
tags:
Exelixis, prostate cancer, ASCO, cabozantinib
Weekend at ASCO: Drugs for Skin, Lung, Ovarian Cancer
WSJ Online
Monday, June 6, 2011 - 9:27pm
tags:
ASCO, melanoma, ovarian cancer, lung cancer, Pfizer, crizotinib, vemurafenib, JNJ, prostate cancer, Roche, Avastin, Zytiga
Algeta shares spike on promising prostate cancer drug data
Fierce Biotech
Monday, June 6, 2011 - 12:34pm
tags:
Algeta, prostate cancer, Apharadin
With promising Ph3 data in hand, Incyte files for myelofibrosis drug OK
Fierce Biotech
Monday, June 6, 2011 - 12:31pm
tags:
Incyte, myelofibrosis, ruxolitinib
Novartis Likely Buyer for Gen-Probe
WSJ Online
Monday, June 6, 2011 - 12:29pm
tags:
Gen-Probe, M&A, Novartis
BioSante Says FDA Lifts Clinical Hold On GVAX Prostate Cancer Vaccine; Shares Up
RTT News
Monday, June 6, 2011 - 11:17am
tags:
BioSante, FDA, vaccines, prostate cancer, GVAX
Dr Reddy's Laboratories Launches 3 Generic Drugs In US
WSJ Online
Monday, June 6, 2011 - 11:11am
tags:
generics, Dr Reddy's, India, Effexor XR, Aricept, Femara
Teva reports positive Phase III blood disease trial results
Globes, Israel
Monday, June 6, 2011 - 11:10am
tags:
Teva Pharmaceuticals, lipegfilgrastim, neutropenia
Sunesis tumbles 16% in early trading
Marketwatch
Monday, June 6, 2011 - 11:08am
tags:
Sunesis, vosaroxin, acute myeloid leukemia
A Quick Roundup Of The New Drugs Presented At This Weekend's Huge Oncology Conference
Yahoo/Business Insider
Monday, June 6, 2011 - 10:25am
tags:
ASCO, Amgen, Aveo Pharmaceutical, Celgene, Medivation, tivozanib, abiraterone, Abraxane, AMG 479, Revlimid
Amylin says drug helped metabolic disease symptoms
Yahoo/AP
Monday, June 6, 2011 - 10:22am
tags:
Amylin, metreliptin, lipodystrophy
Oxigene soars on Nasdaq update
Marketwatch
Monday, June 6, 2011 - 10:20am
tags:
Oxigene, NASDAQ
Roche's vemurafenib plays a starring role at ASCO
Fierce Biotech
Monday, June 6, 2011 - 9:36am
tags:
Roche, ASCO, vemurafenib, Plexxikon, melanoma
10 Reasons to Buy Teva Pharmaceuticals
Seeking Alpha
Monday, June 6, 2011 - 9:27am
tags:
Teva Pharmaceuticals
United Therapeutics’ Treprostinil Met Goal in Study
Bloomberg
Monday, June 6, 2011 - 9:26am
tags:
United Therapeutics, Treprostinil, PAH
Ariad-Merck Cancer Medicine Extends Patients’ Lives in Study
Bloomberg
Monday, June 6, 2011 - 9:24am
tags:
Ariad Pharmaceuticals, Merck, ridaforolimus
Novartis gets European approval for Lucentis as treatment for blocked retinal veins
Yahoo/AP
Monday, June 6, 2011 - 9:22am
tags:
Novartis, Europe, Lucentis, blocked retinal veins
GlaxoSmithKline Investors Nervous After Relovair Reports Mixed Data
Seeking Alpha
Monday, June 6, 2011 - 9:19am
tags:
GSK, investors, Relovair, COPD
Sanofi, Regeneron report progress with cancer drug
Marketwatch
Monday, June 6, 2011 - 9:18am
tags:
Sanofi, Regeneron, Zaltrap, colorectal cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.